Russell Investments Group Ltd. trimmed its position in Novavax, Inc. (NASDAQ:NVAX – Get Rating) by 0.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,582 shares of the biopharmaceutical company’s stock after selling 172 shares during the period. Russell Investments […]
NewEdge Wealth LLC lifted its stake in Marsh & McLennan Companies, Inc. (NYSE:MMC – Get Rating) by 40.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,213 shares of the financial services provider’s stock after buying an additional 1,787 shares during the […]
Commonwealth Equity Services LLC grew its position in shares of John Hancock Multifactor Large Cap ETF (NYSEARCA:JHML – Get Rating) by 4.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 416,529 shares of the company’s stock after purchasing an additional 18,912 shares during […]
Calithera Biosciences (NASDAQ:CALA – Get Rating) had its target price decreased by SVB Leerink from $3.00 to $2.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. SVB Leerink’s price target indicates a potential upside of 444.81% from the company’s previous close. […]
Dubuque Bank & Trust Co. bought a new stake in shares of Uranium Royalty Corp. (NASDAQ:UROY – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 24,000 shares of the company’s stock, valued at approximately $88,000. Other hedge funds and other […]